Helen received her DPhil in Neuroscience from the University of Oxford in 2023. She developed a mouse model of Antidepressant Discontinuation Syndrome, with which she investigated changes in serotonergic signalling using in vivo and ex vivo approaches. Previously, she graduated with an BA in Cell and Systems Biology and a MSc in Neuroscience from the University of Oxford, having gained experience in preclinical studies of neurodegeneration. Helen joins Neuro-Bio as a Senior Scientist to investigate the cellular mechanisms of Alzheimer’s disease in primary neuronal cultures and to develop a novel mouse model of the condition.

Nathalia recently graduated in pharmacy at University of Barcelona. The Pharmaceutical Sciences degree is a 5-year programme during which she was able to join two projects. First, a directed project regarding amyloid aggregate dyes such as Congo red. Second, a thesis about antiviral’s synthesis at the department of Medicinal Chemistry at KU Leuven, Belgium, during the Erasmus + studies programme. Lastly, she spent one month in Seoul, South Korea, at Sookmyung Women’s University at a Plant metabolomics laboratory thanks to the pharmacy Student Exchange Programme (SEP). Nevertheless, her true passion is neuroscience, so she came to Neuro-Bio Ltd. to be able to study Alzheimer’s disease and contribute to this novel approach they present.